NDC 0075-8014-01 - Lovenox
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0075-8014
- Requested NDC
- 0075-8014-01
- Package NDCs from labels
- 0075-8014-01, 0075-8014-10
- Manufacturer
- Sanofi-Aventis U.S. LLC | Sanofi-Aventis Singapore Pte. Ltd. | Sanofi Winthrop Industrie | Patheon Manufacturing Services LLC | Sanofi-Aventis Deutschland GmbH
- Effective date
- 2026-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lovenox | Sanofi-Aventis U.S. LLC | Sanofi-Aventis Singapore Pte. Ltd. | Sanofi Winthrop Industrie | Patheon Manufacturing Services LLC | Sanofi-Aventis Deutschland GmbH | 2026-02-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0075-8014-01 | Lovenox | 0.4 mL in 1 SYRINGE | INJECTION | 0.4 | 15 | |
| 0075-8014-10 | Lovenox | 1 in 1 CELLO PACK | INJECTION | 1 | 15 | |
| 0075-8014-10 | Lovenox | 10 in 1 CARTON | INJECTION | 10 | 15 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0075-8014-01 | ML - Milliliter | 0075-8014 | feee8216-300f-40c6-9408-0da58b6c138d | 1 | 2013-11-04 |
| 0075-8014-10 | ML - Milliliter | 0075-8014 | 37a0323e-1618-4a59-8a5e-730748a04615 | 1 | 2013-11-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| enoxaparin sodium | ACTIVE INGREDIENT | 8NZ41MIK1O | LOVENOX (ENOXAPARIN SODIUM) INJECTION [SANOFI-AVENTIS U.S. LLC] | 3 | |
| enoxaparin | ACTIVE MOIETY | E47C0NF7LV | LOVENOX (ENOXAPARIN SODIUM) INJECTION [SANOFI-AVENTIS U.S. LLC] | 3 | |
| benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | LOVENOX (ENOXAPARIN SODIUM) INJECTION [SANOFI-AVENTIS U.S. LLC] | 3 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | LOVENOX (ENOXAPARIN SODIUM) INJECTION [SANOFI-AVENTIS U.S. LLC] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Thermacare Max Strength Lidocaine | THERMACARE MAX STRENGTH LIDOCAINE | Clarion Brands LLC | 44fed887-d1e0-d205-e063-6294a90ac416 | 2025-12-02 | Warnings | LKG8494WBH |
| Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Rollon | THERMACARE HEAT THERAPY MAX STRENGTH LIDOCAINE PAIN RELIEF ROLLON | Clarion Brands LLC | 4482d34d-eaca-5522-e063-6394a90a6afb | 2025-11-26 | Warnings | LKG8494WBH |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel | THERMACARE HEAT THERAPY MAX STRENGTH LIDOCAINE PAIN RELIEF GEL | Clarion Brands LLC | 445db02a-c8e8-6ebb-e063-6294a90a4301 | 2025-11-24 | Warnings | LKG8494WBH |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
| STERILE WATER | WATER | Henry Schein, Inc. | f4087143-9868-4308-b96c-43657ee8ec28 | 2025-11-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Zilactin Early Relief Cold Sore | BENZYL ALCOHOL | ASCENT CONSUMER PRODUCTS, INC | 42ef8bfa-c4d9-01cf-e063-6394a90ac88a | 2025-11-06 | Warnings | LKG8494WBH |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | 1c0bbcb7-5ed6-4ee7-b297-080d3359474e | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.